Back

Long-term outcomes following DCB vs. DES for ISR treatment

2 September 2024 (10:00 - 10:50)
Organised by: Logo
Congress Presentation Part of: Medical and percutaneous treatment of coronary artery disease Revascularisation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Rafal Januszek

Andrzej Frycz Modrzewski Krakow University, Krakow (Poland)

7 More presentations in this session

Presentation thumbnail
Placebo-controlled efficacy of 17 anti-anginal drugs and percutaneous coronary intervention for first-line treatment of stable angina: systematic review & meta-analysis of 5153 patients from 53 trials
Doctor A. Kaura (London, GB)
Abstract Slides Video
Presentation thumbnail
Three decades of lipid-lowering therapy in type 2 diabetic patients with angiographically proven stable coronary artery disease
Associate Professor H. Drexel (Feldkirch, AT) Doctor A. Mader (Feldkirch, AT)
Abstract Slides Video
Presentation thumbnail
Persistent angina following revascularization for chronic coronary syndromes: a systematic review and meta-analysis of randomized controlled trials
Doctor A. Singh (Los Angeles, US)
Abstract Slides Video
Presentation thumbnail
Comparative meta-analysis: drug-coated balloon versus drug-coated stent - a comprehensive evaluation of efficacy and safety in stentless percutaneous coronary intervention for coronary artery disease
Slides Video
Presentation thumbnail
Effect of primary pci in asymptomatic stemi patients presenting 12 to 48 hours of symptom onset, on myocardial viability assessed by spect tc 99m sestamibi scan epitome99
Doctor M. Pandit (Bangalore, India, IN)
Abstract Slides Video

Access the full session

Session thumbnail
Medical and percutaneous treatment of coronary artery disease

The Event

Event poster

ESC Congress 2024

2 September 2024 10:00 CET
You may be interested in
thumbnail
Congress Session
Strategies and outcomes in in-stent restenosis
thumbnail
Congress Presentation
Long-term outcomes following drug-coated balloons versus thin-strut drug-eluting stents for treatment of in-stent restenosis in chronic kidney failure
thumbnail
Congress Presentation
Drug-coated ballons vs drug-eluting stent in de novo coronary lesions, a propensity-score matched cohort study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources